Withania frutescens
Withania frutescens · Accepted scientific name
Scientific literature: Very Sparse (2 studies) · ★☆☆☆☆
Withania frutescens is a medicinal plant known for its diverse biological activities, most notably its antioxidant and cytotoxic properties. The roots of this species serve as a primary source for therapeutic applications, often utilized through preparations such as extracts and foliar extracts. Chemical analyses of the plant reveal the presence of essential compounds, including the amino acids isoleucine and tryptophan. Historically, various extracts have been employed to address medical conditions such as dysentery, poisoning, and postprandial hyperglycemia. Through these diverse chemical and medicinal profiles, the plant continues to be a subject of significant pharmacological interest.
- Synonyms
- Physalis Suberosa · Physalis Frutescens · 7 more
- Common names
- Not available
- Family
- Solanaceae
- Distribution
- Asia-Tropical
- Plant Parts
- Root
Classification
Common Names
Withania frutescens is a plant known by a diverse array of regional and descriptive names. In various contexts, it is commonly referred to as Campanillera, a name that carries across different linguistic traditions. In specific Spanish-speaking areas, it is recognized as Campanillera (ES) to distinguish its local usage. The species also holds unique regional titles such as Erva-moura-sonífera-da-arrábida and Tomateiro-da-arrábida. Finally, it is frequently identified by its more formal derivative, Withanie frutescente.
Sources: Catalogue of Life (COL)
Synonyms
Withania frutescens is a botanical subject that has been documented under several different names throughout various scientific studies. Historically, this plant has been identified by the synonym Atropa frutescens in certain taxonomic records. It has also been referred to as Hypnoticum frutescens and Opsago cordata in different botanical contexts. Furthermore, the species has been categorized under the names Opsago suberosa and Physalis frutescens. Understanding these various synonyms is essential for accurately tracking the plant's identity across diverse scientific literature.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Withania frutescens is a fascinating specimen belonging to the vast kingdom Plantae. Within this diverse realm, the plant is classified under the class Equisetopsida. It further resides in the order Solanales, showcasing its specific evolutionary placement. This species is a distinguished member of the genus Withania. Finally, it finds its botanical home within the well-known family Solanaceae.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Solanales |
| Family | Solanaceae |
| Genus | Withania |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Withania frutescens displays a broad geographical range that spans across Africa and parts of Europe. Its distribution is particularly prominent throughout the African continent, including the Macaronesia and Canary Islands. Within Northern Africa, the species is well-established in the specific regions of Algeria, Morocco, and Tunisia. The plant's reach also extends into Europe, where it can be found within the Baleares. This widespread presence highlights the adaptability of the species across diverse Mediterranean and subtropical landscapes.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Withania frutescens is a self-supporting shrub characterized by its sturdy and upright growth form. This plant typically reaches a maximum height of 2 meters as it matures. Its structural resilience allows it to thrive as a standalone feature in various landscapes.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Withania frutescens possesses diverse biological properties that make it a subject of significant pharmacological interest. Research indicates that the plant exhibits notable antioxidant activity, which helps mitigate oxidative damage and improve physiological indices such as testosterone levels and sperm count. Beyond its protective roles, the species also demonstrates significant cytotoxic potential against specific cancer cell lines. Studies have shown that certain isolated withanolides from its leaves can effectively inhibit the growth of tumor cells, with some compounds performing comparably to standard anticancer drugs. Consequently, these dual capabilities suggest that the plant holds immense potential for development in both medicinal and pharmaceutical applications.
Compounds
Withania frutescens is a plant species recognized for its significant concentration of bioactive phytochemical substances. Research indicates that the plant contains polyphenols, which are largely responsible for its impressive antioxidant capacity. In addition to these compounds, the species is a rich source of withanolides that contribute to its diverse biological properties. Specifically, these withanolides have been linked to the plant's observed antimicrobial activities. Furthermore, certain isolated withanolides from the leaves have demonstrated potent cytotoxic potential, offering promise for future anticancer drug development.
Conditions
Withania frutescens demonstrates significant therapeutic potential by treating various cancer cell lines, including HepG2 and HT29. Specifically, certain isolated compounds from the plant exhibit strong cytotoxic activity against the HT29 cell line. Research also indicates that the plant can treat diabetes by managing high fasting blood glucose levels and inhibiting alpha-amylase and alpha-glucosidase activities. Furthermore, traditional therapies have utilized this plant to treat dysentery and gastric ulceration. These diverse biological properties highlight its multifaceted medicinal applications in treating several different conditions.
Preparations
Withania frutescens is prepared as an extract, specifically in the form of a hydroethanolic preparation used for various medicinal studies. This plant is prepared as a foliar extract to investigate its phytochemical composition and therapeutic potential. Research indicates that the foliar extract of this species can be used to study inhibitory effects on enzymes like alpha-amylase and alpha-glucosidase. Furthermore, the preparation of the extract allows for the assessment of its antidiabetic and antihyperglycemic activities in animal models. These studies confirm that the extract of Withania frutescens can be administered safely in both acute and subacute toxicity tests.
Parts used
Withania frutescens utilizes its root as a primary source for extracting potent bioactive compounds. Recent research highlights how the root extract can effectively mitigate testicular damage caused by lead acetate exposure in animal models. Through detailed GC-MS analysis, scientists have identified various phytochemical components within the root that contribute to its antioxidant and anti-inflammatory properties. The study demonstrated that administering the root extract significantly improves testosterone levels and increases sperm count. Consequently, this plant part holds great potential for future pharmaceutical and medicinal applications targeting male reproductive health.